Showing 41 - 60 results of 173 for search '"movement disorder"', query time: 0.04s Refine Results
  1. 41

    The Contribution of α-Synuclein Spreading to Parkinson’s Disease Synaptopathy by Francesca Longhena, Gaia Faustini, Cristina Missale, Marina Pizzi, PierFranco Spano, Arianna Bellucci

    Published 2017-01-01
    “…In sporadic PD, the most common age-related neurodegenerative movement disorder, nigrostriatal dopaminergic deficits are responsible for the onset of motor symptoms that have been related to α-synuclein deposition at synaptic sites. …”
    Get full text
    Article
  2. 42

    Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review by Carlos E. Mantese, Artur Schumacher-Schuh, Carlos R. M. Rieder

    Published 2018-01-01
    “…A recent review by the Movement Disorder Society suggested the 19-item (WOQ-19) and 9-item (WOQ-9) questionnaires as screening tools for the wearing-off phenomenon. …”
    Get full text
    Article
  3. 43

    Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson’s Disease: Online-Based Delphi Survey by Atsushi Takeda, Yoshio Tsuboi, Masahiro Nomoto, Hideki Mochizuki, Nobutaka Hattori

    Published 2022-01-01
    “…To summarize opinions on the optimal patient profile and methods of using safinamide in common clinical scenarios, Japanese movement disorder specialists with expertise in PD investigated the perspectives of neurologists and neurosurgeons. …”
    Get full text
    Article
  4. 44

    Kinect-Based Exergames Tailored to Parkinson Patients by Ioannis Pachoulakis, Nikolaos Papadopoulos, Anastasia Analyti

    Published 2018-01-01
    “…Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder where motor dysfunction gradually increases. …”
    Get full text
    Article
  5. 45

    Rehabilitation of Speech and Swallowing Disorder in a Patient With Severe Brain Injury in the Subacute Phase: A Case Report by Morteza Farazi, Niyayesh Aali, Seyed Majid Akhvan Hejazi

    Published 2025-03-01
    “…Dysarthria is a speech movement disorder caused by damage to the central nervous system. …”
    Get full text
    Article
  6. 46

    Insomnia: definition, pathophysiological models, diagnosis, and treatment by E. Sakalauskaitė-Juodeikienė, R. Masaitienė

    Published 2018-09-01
    “…Polysomnography is recommended when other sleep disorders (periodic limb movement disorder, sleep apnea or narcolepsy) are suspected, also for treatment-resistant insomnia. …”
    Get full text
    Article
  7. 47

    The Parkinson’s Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge by Dávid Pintér, Pablo Martinez-Martin, József Janszky, Norbert Kovács

    Published 2019-01-01
    “…To investigate the correlation between changes in the motor examination part of the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and the PDCS motor scores during acute levodopa challenge and calculate a cutoff range on the PDCS indicating clinically relevant improvement. …”
    Get full text
    Article
  8. 48

    “Does the Response to Morning Medication Predict the ADL-Level of the Day in Parkinson’s Disease?” by Trine Hørmann Thomsen, Troels Wesenberg Kjær, Lene Bastrup Jørgensen, Anita Haahr, Kristian Winge

    Published 2020-01-01
    “…Data collection encompasses measurements from the Parkinson KinetiGraph, and the ADL-limitations are assessed by the Movement Disorder Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part II. …”
    Get full text
    Article
  9. 49

    SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities by Michael Zech, Katharina Poustka, Sylvia Boesch, Riccardo Berutti, Tim M. Strom, Wolfgang Grisold, Werner Poewe, Juliane Winkelmann

    Published 2017-01-01
    “…Aged 43 years, our female index patient demonstrated abrupt onset of mixed generalized hyperkinesia, with dystonic and choreiform movements being the most salient features. The movement disorder was accompanied by behavioral problems such as anxiety and mood instability. …”
    Get full text
    Article
  10. 50

    Deciphering Parkinson’s Disease through Eye Movements: A Promising Tool for Early Diagnosis in the Face of Cognitive Impairment by Xianglian Liao, Jian Yao, Hongyin Tang, Yilan Xing, Xin Zhao, Daao Nie, Ping Luan, Guihua Li

    Published 2024-01-01
    “…In this article, we review the correlation between cognitive impairment and eye movement disorder in patients with PD.…”
    Get full text
    Article
  11. 51

    Treatment of tardive dyskinesia caused by long-term antipsychotic use: case reports and literature review by I. Pabarčiūtė, M. Karnickas

    Published 2020-12-01
    “…Tardive dyskinesia is a movement disorder that begins with exposure to dopamine receptor-blocking agents for at least a few months. …”
    Get full text
    Article
  12. 52

    Validation of the Official Slovak Version of the Unified Dyskinesia Rating Scale (UDysRS) by Matej Skorvanek, Michal Minar, Milan Grofik, Katarina Kracunova, Vladimir Han, Frantisek Cibulcik, Jan Necpal, Ladislav Gurcik, Peter Valkovic

    Published 2015-01-01
    “…The Slovak version of the UDysRS was designated as an official non-English translation and can be downloaded from the website of the International Parkinson and Movement Disorder Society.…”
    Get full text
    Article
  13. 53

    A pilot exploratory study for analysis of clinical features and plasma catecholamines in blepharospasm by Lixia Zhu, Hongmei Meng, Wuqiong Zhang, Lijuan Wang, Weixuan Zhao, Jiaai Li, Nilupaer Shafeng, Huaiyu Sun, Ting Jiang, Huiqing Liu, Yu Guo, Shuai Hou

    Published 2025-01-01
    “…Abstract Blepharospasm (BSP) is a common focal movement disorder linked to the basal ganglia and plasma catecholamines (CAs). …”
    Get full text
    Article
  14. 54

    Reliability and Validity of the Persian Version of the Fatigue Severity Scale in Idiopathic Parkinson’s Disease Patients by Seyed-Mohammad Fereshtehnejad, Hasti Hadizadeh, Farzaneh Farhadi, Gholam Ali Shahidi, Ahmad Delbari, Johan Lökk

    Published 2013-01-01
    “…Ninety nondemented idiopathic Parkinson’s disease (IPD) patients were consecutively recruited from an outpatient referral movement disorder clinic. In addition to the disease severity scales, the FSS-Per was used for fatigue measurement. …”
    Get full text
    Article
  15. 55

    Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis by Osamu Kano, Hiroshi Tsuda, Ayako Hayashi, Masaki Arai

    Published 2022-01-01
    “…Outcomes included change in wearing-off time, Unified Parkinson’s Disease Rating Scale (UPDRS)/Movement Disorder Society-UPDRS (MDS-UPDRS) II and III scores, treatment-emergent adverse events (TEAEs), and Parkinson’s Disease Questionnaire (PDQ-39) summary index score. …”
    Get full text
    Article
  16. 56

    Alterations of Interhemispheric Functional Connectivity and Degree Centrality in Cervical Dystonia: A Resting-State fMRI Study by Wenyan Jiang, Yiwu Lei, Jing Wei, Lu Yang, Shubao Wei, Qiong Yin, Shuguang Luo, Wenbin Guo

    Published 2019-01-01
    “…Cervical dystonia (CD) is a neurological movement disorder characterized by involuntary head and neck movements and postures. …”
    Get full text
    Article
  17. 57

    Comparison of the efficacy and safety of bupropion versus aripiprazole augmentation in adults with treatment-resistant depression: a nationwide cohort study in South Korea by Dong Yun Lee, Rae Woong Park, Soo Min Jeon

    Published 2025-01-01
    “…Bupropion was associated with lower risks of hospitalization (hazard ratio [HR]: 0.51; 95% confidence interval [CI] 0.29–0.86) and movement disorders (HR: 0.56; 95% CI 0.36–0.85) than aripiprazole. …”
    Get full text
    Article
  18. 58

    Retrospective database analysis on the demographics and resource utilization of patients with Parkinson’s disease in Quebec, Canada by Véronique Baribeau, Shawn Mohammed, Amnah Awan, Diana Parison, Jean Lachaine

    Published 2025-01-01
    “…Introduction: Parkinson’s disease (PD) is the most prevalent neurodegenerative movement disorder. Despite its recognized significance, there remains a paucity of recent studies reporting treatment utilization and the economic impact of PD in a real-world setting, especially in Canada. …”
    Get full text
    Article
  19. 59

    Peripheral nerve injury induces dystonia-like movements and dysregulation in the energy metabolism: A multi-omics descriptive study in Thap1+/− mice by Colette Reinhold, Susanne Knorr, Rhonda L. McFleder, Lisa Harder-Rauschenberger, Tom Gräfenhan, Andreas Schlosser, Michael Sendtner, Jens Volkmann, Chi Wang Ip

    Published 2025-02-01
    “…DYT-THAP1 dystonia is a monogenetic form of dystonia, a movement disorder characterized by the involuntary co-contraction of agonistic and antagonistic muscles. …”
    Get full text
    Article
  20. 60